CD123/CLL1 CAR-T cells
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for CD123/CLL1 CAR-T cells, covering 2020-01-02 to 2020-01-02. Get the full timeline:
Most recent: Clinical Trial Update: CD123/CLL1 CAR-T Cells for R/R AML (STPHI_0001) [Phase 2, Phase 3]